Journal article
Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in papua, indonesia: A longitudinal surveillance study
E Kenangalem, JR Poespoprodjo, NM Douglas, FH Burdam, K Gdeumana, F Chalfein, undefined Prayoga, F Thio, A Devine, J Marfurt, G Waramori, S Yeung, R Noviyanti, P Penttinen, MJ Bangs, P Sugiarto, JA Simpson, Y Soenarto, NM Anstey, RN Price
Plos Medicine | PUBLIC LIBRARY SCIENCE | Published : 2019
Abstract
Background Malaria control activities can have a disproportionately greater impact on Plasmodium falciparum than on P. vivax in areas where both species are coendemic. We investigated temporal trends in malaria-related morbidity and mortality in Papua, Indonesia, before and after introduction of a universal, artemisinin-based antimalarial treatment strategy for all Plasmodium species. Methods and findings A prospective, district-wide malariometric surveillance system was established in April 2004 to record all cases of malaria at community clinics and the regional hospital and maintained until December 2013. In March 2006, antimalarial treatment policy was changed to artemisinin combination ..
View full abstractRelated Projects (3)
Grants
Awarded by Wellcome Trust
Funding Acknowledgements
The study was funded by the Wellcome Trust (Senior Fellowship in Clinical Science to RNP 200909), the Bill and Melinda Gates Foundation (OPRA, OPP1054404), and the Australian National Health and Medical Research Council (the HOT NORTH initiative #1131932 and Fellowships to JAS #110975 and NMA #1135820; and the Australian Centre of Research Excellence on Malaria Elimination, ACREME #1134989). The Timika Research Facility and Papuan Community Health Foundation is supported by the Australian Department of Foreign Affairs and Trade (DFAT #74431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.